Neuren Pharmaceuticals Limited (ASX:NEU) STOCK PERFORMANCE WATCH:
Neuren Pharmaceuticals Limited (ASX:NEU) has five years performance of -34.166667% and weekly performance of -3.658537%. The stock has been moved at -60.10101% throughout last twelve months. The stock has performed -12.222222% around last thirty days, and changed -16.549296% over the last three months.
Neuren Pharmaceuticals Limited (ASX:NEU) stock has performed -0.42% and changed AUD$ -0.005 while share value reached at AUD$ 1.185 in last trading session. At present, the stock 52 week high price sited at 3.48 and 52 week low situated at 1.005. 176774 shares traded on hands while it’s an average volume stands with 58200 shares. The current analyst consensus rating clocked at 2 on company shares. Analysts estimated that stock to reach value at AUD$ 2.28 price in one-year period.
Average true range percent (ATRP-14) measured at 2.54%. Volatility or average true range percent (ATRP 14) is the ATR expressed as a percentage of closing price. Average true range percent (ATRP) measures volatility on a relative level. This is opposed to the ATR, which measures volatility on an absolute level. ATRP allows securities to be compared whereas ATR does not. That means lower-priced stocks won’t necessarily have lower ATR values than higher-priced stocks. The Company’s beta coefficient sits at 0.7848. Beta factor measures the amount of market risk associated with market trade. Higher the beta discloses more riskiness and lower the beta lower the risk.
The company’s net profit margin is 21.97%. It measures how much out of every dollar of sales a company actually keeps in earnings. Operating Margin is seen at 41.57%. Return on Assets (ROA) an indicator of how profitable a company is relative to its total assets is 16.30%. Return on Equity (ROE) is 14.98%.
MARKET CAPITALIZATION AND VALAATION INDICATORS:
Neuren Pharmaceuticals Limited (ASX:NEU) is New Zealand based company. Currently it has a market worth of AUD$ 84027073.0688. Using market capitalization to show the size of a company is important because company size is a basic determinant of various characteristics in which investors are interested, including risk. P/E ratio is noted at 38.225803. P/E is a popular valuation ratio of a company’s current share price compared to its per-share earnings (trailing twelve months). P/S ratio of 8.484566 reflects the value placed on sales by the market. P/B ratio is 4.817073. P/B is used to compare a stock’s market value to its book value.
Now The company has RSI figure of 39.55. The Relative Strength Index (RSI) was developed by J. Welles Wilder, and it reading fluctuates between 0 and 100. The RSI is a momentum oscillator that measures the speed and change of stock price movements. Generally, the when RSI falls below 30 then stock considered to be oversold and overbought when it moves above 70. The normal reading of a stock will fall in the range of 30 to 70. RSI can be used to detect general trends as well as finding divergences and failure swings.
ADX value listed at 21.64. The values of ADX range from 0 to 100 and are also important for distinguishing between trends and non-trends. Many traders will use ADX readings above 25 to suggest that the trend’s strength is strong enough for trend trading strategies. Conversely, when ADX is below 25, many will avoid trend trading strategies.